Infection Surveillance Solution Market - Forecasts from 2020 to 2025
The infection surveillance solution market is estimated to grow at a CAGR of 12.23% to reach US$700.647 million by 2025, from US$350.627 million in 2019. The increasing number of cases of healthcare-associated infections (HAIs) and improving infection control and control solutions are leading to an increase in the adoption of infection surveillance solutions to aid in the proper and effective monitoring of the state of infections in the patients and healthcare facilities. Healthcare-associated infections are one of the most common types of infections that are acquired by the patients whilst they are undergoing treatment at hospitals, which have improper sanitation and do not adhere to the disinfection and infection control and prevention policies and the stringent guidelines provided strictly. According to the statistics provided by the World Health Organization, nosocomial infections, which are generally referred to as healthcare-associated infections are increasingly frequent and an adverse event that plagues the health care facilities and healthcare delivery globally. There are approximately 7 in the developed countries and around 10 in developing countries out of the admitted 100 patients that are prone to and will acquire at least one type of healthcare-associated infection. The patients that are admitted to the neonates and the intensive care units (ICUs) are also prone to the epidemic burden of healthcare-associated infections that too more in low-income and middle-income countries than the countries with high income.
In addition, the most common infection acquired during the provision of healthcare services is the urinary tract infection (UTI) and the infection that burdens lesser-equipped health care settings are the surgical site infections (SSIs) and affects about one-third of the operated patients, which is up to nine times more than in the developed countries. In high-income economies, about 30% of patients in ICUs contract at least one of the healthcare-associated infections, in the middle-income and low-income economies the ICU associated infections rate is two or three times more and device-associated infections are 13 times higher than the US. Even the newborns are at high risk in developing countries, with the rate of infections three times or 20 times higher than high-income countries. This is leading to the market players adopting infection surveillance solutions in order to effectively maintain the state of the hospital treatments, hospital surroundings, and all the devices and hygiene-related practices that are essential to a achieve a high infection control and infection prevention to minimize the spread of nosocomial infections. Thus, it is a playing a key role in augmenting the market growth over the forecast period.
The increasing participation of the core organizations in taking steps in order to tackle the problem of the spread of infection during hospital treatment and encourage different healthcare facilities to make use of infection surveillance solutions.
The Hospital Epidemiology and Infection Control, (HEIC), which is a part of John Hopkins Hospital (JHH), has two main objectives, to effectively perform comprehensive surveillance for healthcare-associated infections and in order to create, implement, support and sustain interventions based in evidence in order to prevent HAI’s. This department makes use of the definitions of infection surveillance as provided by the Centers for Disease Control and Prevention (CDC) National Health and Safety Network. The hospital staff from HEIC provides feedback of hand hygiene performance and infection surveillance data to each hospital unit weekly. The data trends in regard to hand hygiene, healthcare-associated infections, and multi-drug resistant prevention programs are also being reported on a wide range of institutional dashboards as well as quality reports. The major requirement of an effective and comprehensive must include all the HEIC participation in the several unit-based root cause analyses of each of the infections and programs to promote, monitor and sustain the evidence-based practices.
The segments that need to be paid attention to that require measures are hand hygiene, Healthcare-associated infections, Multi-drug Resistant Organisms (MDROs).
Product Offerings by Major Market Players
The better, advanced and diverse varieties of Infection Surveillance solutions and services with enhanced properties that are able to effectively prevent contamination and spread of diseases to the end-users. These products are being offered by existing and new players in different markets is estimated to lead to increased adoption and propel the market growth further over the forecast period.
Some of the examples of the product offerings are as follows:
The well-positioned healthcare industry and the provision of one the best healthcare facilities in countries such as the US and the awareness programs being promoted are expected to aid the North American region to hold a significant market share over the forecast period. The Asia Pacific region is also estimated to increase is hare over the forecast period, which is attributable to the increasing number of investments in order to accelerate the development of the healthcare industry and providing better healthcare services to the low-income population.
Segmentation:
In addition, the most common infection acquired during the provision of healthcare services is the urinary tract infection (UTI) and the infection that burdens lesser-equipped health care settings are the surgical site infections (SSIs) and affects about one-third of the operated patients, which is up to nine times more than in the developed countries. In high-income economies, about 30% of patients in ICUs contract at least one of the healthcare-associated infections, in the middle-income and low-income economies the ICU associated infections rate is two or three times more and device-associated infections are 13 times higher than the US. Even the newborns are at high risk in developing countries, with the rate of infections three times or 20 times higher than high-income countries. This is leading to the market players adopting infection surveillance solutions in order to effectively maintain the state of the hospital treatments, hospital surroundings, and all the devices and hygiene-related practices that are essential to a achieve a high infection control and infection prevention to minimize the spread of nosocomial infections. Thus, it is a playing a key role in augmenting the market growth over the forecast period.
The increasing participation of the core organizations in taking steps in order to tackle the problem of the spread of infection during hospital treatment and encourage different healthcare facilities to make use of infection surveillance solutions.
The Hospital Epidemiology and Infection Control, (HEIC), which is a part of John Hopkins Hospital (JHH), has two main objectives, to effectively perform comprehensive surveillance for healthcare-associated infections and in order to create, implement, support and sustain interventions based in evidence in order to prevent HAI’s. This department makes use of the definitions of infection surveillance as provided by the Centers for Disease Control and Prevention (CDC) National Health and Safety Network. The hospital staff from HEIC provides feedback of hand hygiene performance and infection surveillance data to each hospital unit weekly. The data trends in regard to hand hygiene, healthcare-associated infections, and multi-drug resistant prevention programs are also being reported on a wide range of institutional dashboards as well as quality reports. The major requirement of an effective and comprehensive must include all the HEIC participation in the several unit-based root cause analyses of each of the infections and programs to promote, monitor and sustain the evidence-based practices.
The segments that need to be paid attention to that require measures are hand hygiene, Healthcare-associated infections, Multi-drug Resistant Organisms (MDROs).
Product Offerings by Major Market Players
The better, advanced and diverse varieties of Infection Surveillance solutions and services with enhanced properties that are able to effectively prevent contamination and spread of diseases to the end-users. These products are being offered by existing and new players in different markets is estimated to lead to increased adoption and propel the market growth further over the forecast period.
Some of the examples of the product offerings are as follows:
- In May 2019, RLDatix, one of the leading companies that is involved in providing healthcare solutions that provide patients safety solutions, quality improvement, and harm reduction in healthcare announced that they entered into and acquisition agreement in order to acquire iContracts, which is one the leading companies dealing in clouds based solutions for risk management. By this acquisition, the proper and more effective policies can be implemented.
- Wolters Kluwer, one to the leading company dealing in the provision of software solutions and services to cater to the demands from clinics and healthcare facilities for is improving the product is already provides called the “Sentri 7” for adhering to the strict regulations for the infection control and prevention. Artificial Intelligence technology is being added to his product to cater to rising cases of infections caused by the bacteria responsible for this and called the Clostridioides difficile, or C.diff, and is responsible for many deaths and is a major concern among the healthcare providers and workers. In addition, it is able to facilitate the rapid treatment of patients and improving the treatment outcomes.
The well-positioned healthcare industry and the provision of one the best healthcare facilities in countries such as the US and the awareness programs being promoted are expected to aid the North American region to hold a significant market share over the forecast period. The Asia Pacific region is also estimated to increase is hare over the forecast period, which is attributable to the increasing number of investments in order to accelerate the development of the healthcare industry and providing better healthcare services to the low-income population.
Segmentation:
- By Solution Type
- Software
- Services
- By Deployment Mode
- On-premise
- Cloud
- By End-User
- Clinics
- Hospitals
- Laboratories
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Others
- Asia Pacific
- Japan
- China
- India
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. INFECTION SURVEILLANCE MARKET ANALYSIS, BY SOLUTION TYPE
5.1. Introduction
5.2. Software Services
6. INFECTION SURVEILLANCE MARKET ANALYSIS, BY DEPLOYMENT MODE
6.1. Introduction
6.1.1. On-Premise
6.1.2. Cloud
7. INFECTION SURVEILLANCE MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Clinics
7.3. Hospitals
7.4. Laboratories
8. INFECTION SURVEILLANCE MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America Infection Surveillance Market, By Solution Type
8.2.2. North America Infection Surveillance Market, By Deployment Mode
8.2.3. North America Infection Surveillance Market, By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. South America Infection Surveillance Market, By Solution Type
8.3.2. South America Infection Surveillance Market, By Deployment Mode
8.3.3. South America Infection Surveillance Market, By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Infection Surveillance Market, By Solution Type
8.4.2. Europe Infection Surveillance Market, By Deployment Mode
8.4.3. Europe Infection Surveillance Market, By End-User
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa Infection Surveillance Market, By Solution Type
8.5.2. Middle East and Africa Infection Surveillance Market, By Deployment Mode
8.5.3. Middle East and Africa Infection Surveillance Market, By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. United Arab Emirates
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Infection Surveillance Market, By Solution Type
8.6.2. Asia Pacific Infection Surveillance Market, By Deployment Mode
8.6.3. Asia Pacific Infection Surveillance Market, By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. RL Solutions
10.2. Cerner Corporation
10.3. VigiLanz Corporation
10.4. IBM
10.5. GOJO Industries, Inc.
10.6. Wolters Kluwer
10.7. Premier
10.8. BD
10.9. Baxter
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. INFECTION SURVEILLANCE MARKET ANALYSIS, BY SOLUTION TYPE
5.1. Introduction
5.2. Software Services
6. INFECTION SURVEILLANCE MARKET ANALYSIS, BY DEPLOYMENT MODE
6.1. Introduction
6.1.1. On-Premise
6.1.2. Cloud
7. INFECTION SURVEILLANCE MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Clinics
7.3. Hospitals
7.4. Laboratories
8. INFECTION SURVEILLANCE MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America Infection Surveillance Market, By Solution Type
8.2.2. North America Infection Surveillance Market, By Deployment Mode
8.2.3. North America Infection Surveillance Market, By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. South America Infection Surveillance Market, By Solution Type
8.3.2. South America Infection Surveillance Market, By Deployment Mode
8.3.3. South America Infection Surveillance Market, By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Infection Surveillance Market, By Solution Type
8.4.2. Europe Infection Surveillance Market, By Deployment Mode
8.4.3. Europe Infection Surveillance Market, By End-User
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa Infection Surveillance Market, By Solution Type
8.5.2. Middle East and Africa Infection Surveillance Market, By Deployment Mode
8.5.3. Middle East and Africa Infection Surveillance Market, By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. United Arab Emirates
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Infection Surveillance Market, By Solution Type
8.6.2. Asia Pacific Infection Surveillance Market, By Deployment Mode
8.6.3. Asia Pacific Infection Surveillance Market, By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. RL Solutions
10.2. Cerner Corporation
10.3. VigiLanz Corporation
10.4. IBM
10.5. GOJO Industries, Inc.
10.6. Wolters Kluwer
10.7. Premier
10.8. BD
10.9. Baxter
